Fujifilm’s Synapse PACS is First System Granted Authority to Operate under New U.S. DoD Process

Medical Systems U.S.A., Inc.
, a leading provider of diagnostic
imaging products and medical informatics solutions, today announced that
its Synapse PACS line has been granted Authority to Operate (ATO) on
networks in the U.S. Department of Defense (DoD), making Fujifilm the
first vendor with a networked medical system to attain a Risk Management
Framework (RFM)-based ATO.

“This particular ATO is an unprecedented achievement in that our
technology had to stand up to the rigors of a brand new risk management
framework process recently implemented by the Department of Defense,”
said Johann Fernando, Ph.D, Chief Operating Officer, FUJIFILM Medical
Systems U.S.A., Inc. “The fact that Fujifilm is the very first vendor to
meet these new challenges speaks to our unrivalled history of
innovation, flexibility and stringent security standards.”

In the past year, the DoD transitioned from its traditional DIACAP
process to a new RMF process for evaluating technologies and determining
ATO status. The new process contains thousands of changes and generally
takes over a year to complete.

The Risk Management Framework provides a process that integrates
security and risk management activities into the system development life
cycle. The risk-based approach to security control selection and
specification considers effectiveness, efficiency, and constraints due
to applicable laws, directives, Executive Orders, policies, standards,
or regulations.

After completing a thorough security assessment, the DoD determined that
Fujifilm’s Synapse PACS line meets its controls for RMF including the
DoD 8500 Series controls and the Security and Technical Implementation
Guides (STIG) requirements. The new ATO granted to Fujifilm is valid
until March 2020.

“This latest ATO from the Department of Defense is testimony to the fact
that risk mitigation remains a top priority at Fujifilm,” said Bill
Lacy, Vice President of Medical Informatics at FUJIFILM Medical Systems
U.S.A., Inc. “We look forward to our continued strong relationship with
the DoD.”

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of
diagnostic imaging products and medical informatics solutions to meet
the needs of healthcare facilities today and well into the future. From
an unrivaled selection of digital x-ray systems, to the Synapse® brand
of PACS, RIS and cardiovascular products, to advanced women’s health
imaging systems, Fujifilm has products that are ideal for any size
imaging environment. The Endoscopy Division of FUJIFILM Medical Systems
U.S.A., Inc. supplies high quality, technologically advanced FUJINON
brand endoscopes to the medical market. TeraMedica Division delivers
healthcare informatics, and is the leading provider of vendor neutral,
enterprise-wide solutions for unrestricted medical image management.
FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT.
For more information please visit www.fujifilmhealthcare.com
and www.fujifilmendoscopy.com.

FUJIFILM Holdings Corporation, Tokyo, Japan brings continuous innovation
and leading-edge products to a broad spectrum of industries, including:
healthcare, with medical systems, pharmaceuticals and cosmetics; graphic
systems; highly functional materials, such as flat panel display
materials; optical devices, such as broadcast and cinema lenses; digital
imaging; and document products. These are based on a vast portfolio of
chemical, mechanical, optical, electronic, software and production
technologies. In the year ended March 31, 2016, the company had global
revenues of $22.1 billion, at an exchange rate of 112.54 yen to the
dollar. Fujifilm is committed to environmental stewardship and good
corporate citizenship. For more information, please visit: www.fujifilmholdings.com.

All product and company names herein may be trademarks of their
registered owners.


Lauren Geloso, 914-798-8303